Bosa Mirjanić-Azarić, Smiljana Mijić, Zana Radić-Savić, Siniša Stanković, Dragana Malčić-Zanić, Egeljić Nataša Mihailović, Đorđe Stojisavljević, Bojana Ivetić, Nataša Bogavac-Stanojević
BACKGROUND: This pilot study aimed to assess the potential of cystatin C (Cys C) as a biomarker in non-Hodgkin lymphoma (NHL) and to explore its association with paraoxonase 1 (PON1) activity.
METHODS: The study included 44 patients with B-cell NHL and 44 healthy subjects. Cys C was measured using the Cobas e 801 analyser (Roche Diagnostics GmbH, Mannheim, Germany), while PON1 and TAS were measured on the ILab 300+ system (Instrumentation Laboratory, Milan, Italy).